How it works:
Tesamorelin is a growth hormone releasing hormone (GHRH) analog that increases IGF-1 levels in both men and women. It binds to and
stimulates GHRH receptors with similar potency as endogenous GHRH. Other benefits include nootropic effects and reducing triglycerides.
Tesamorelin has subsequently been shown to decrease carotid intima-medial thickness (cIMT), visceral adipose tissue (VAT), and c-reactive
protein (CRP).
Key Benefits:
Clinical trials have shown that Tesamorelin significantly reduces abdominal fat. Additionally, it can improve cognitive function for seniors and
patients with an increased risk of Alzheimer’s disease, due to mild cognitive impairment.
Content & Potency:
Injectable
2.5mg Vial: Reconstitute 5ml with BWFI (.5mg/ml – 5ml)
5mg Vial: Reconstitute 5ml with BWFI (1mg/ml – 5ml)
.20ml daily or .10ml twice a day subcutaneously
RETATRUTID
July 2, 2025